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Decretins, hormones induced by fasting that sup-
press insulin production and secretion, have been
postulated from classical human metabolic studies.
From genetic screens, we identified Drosophila Li-
mostatin (Lst), a peptide hormone that suppresses
insulin secretion. Lst is induced by nutrient restric-
tion in gut-associated endocrine cells. limostatin
deficiency led to hyperinsulinemia, hypoglycemia,
and excess adiposity. A conserved 15-residue poly-
peptide encoded by limostatin suppressed secretion
by insulin-producing cells. Targeted knockdown
of CG9918, a Drosophila ortholog of Neuromedin U
receptors (NMURs), in insulin-producing cells phe-
nocopied limostatin deficiency and attenuated insu-
lin suppression by purified Lst, suggesting CG9918
encodes an Lst receptor. NMUR1 is expressed in
islet b cells, and purified NMU suppresses insulin
secretion from human islets. A human mutant NMU
variant that co-segregates with familial early-onset
obesity and hyperinsulinemia fails to suppress insu-
lin secretion. We propose Lst as an index member
of an ancient hormone class called decretins, which
suppress insulin output.
INTRODUCTION
The coupling of hormonal responses to nutrient availability is
fundamental for metabolic control. In mammals, regulated
secretion of insulin frompancreatic b cells is a principal hormonal
response orchestrating metabolic homeostasis. Circulating in-
sulin levels constitute a dynamic metabolic switch, signaling
the fed state and nutrient storage (anabolic pathways) when
elevated, or starvation and nutrient mobilization (catabolic path-Cell Mways) when decreased (Cahill, 1971; Saltiel and Kahn, 2001).
Thus, insulin secretion must be precisely tuned to the nutritional
state of the animal. Increased circulating glucose stimulates
b cell depolarization and insulin secretion (Rorsman and Braun,
2013). In concert with glucose, gut-derived incretin hormones
amplify glucose-stimulated insulin secretion (GSIS) in response
to ingested carbohydrates, thereby tuning insulin output to the
feeding state of the host (La Barre, 1932; Campbell and Drucker,
2013; Creutzfeldt, 2005).
While the incretin effect on insulin secretion during feeding is
well-documented, counter-regulatory mechanisms that sup-
press insulin secretion during or after starvation are incompletely
understood (Campbell and Drucker, 2013; Longo and Mattson,
2014). Classical starvation experiments in humans and other
mammals revealed that sustained fasting profoundly alters the
dynamics of insulin production and secretion, resulting in im-
paired glucose tolerance, relative insulin deficits, and ‘‘starvation
diabetes’’ (Cahill et al., 1966; Fery et al., 1990; Fink et al., 1974;
Hofmeister, 1890; Lilavivathana et al., 1978; Unger et al., 1963).
Remarkably, starvation-induced suppression of GSIS was not
reverted by normalizing circulating glucose levels, suggesting
that the dampening effect of starvation on insulin secretion per-
dures and is uncoupled from blood glucose and macronutrient
concentrations (Lilavivathana et al., 1978). Based on these ob-
servations, it has been postulated that hormonal signals induced
by fasting may actively attenuate insulin secretion (Lilavivathana
et al., 1978; Unger et al., 1963). Ensinck et al. (1997) suggested
that enteroendocrine ‘‘decretin’’ hormones may constrain the
release of insulin to prevent hypoglycemia. This concept is
further supported by recent studies identifying a G protein that
suppresses insulin secretion from pancreatic b cells (Wang
et al., 2011). Thus, after nutrient restriction, decretin hormones
could signal through G protein-coupled receptors (GPCRs) to
attenuate GSIS from b cells.
The discovery of hormonal pathways regulating metabolism in
mammals presents a formidable challenge. However, progress
has revealed conserved mechanisms of metabolic regulation
by insulin and glucagon-like peptides in Drosophila, providingetabolism 21, 323–333, February 3, 2015 ª2015 Elsevier Inc. 323
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Figure 1. Loss of Lst, a Starvation-Regulated Prepropeptide, Causes Hyperinsulinemia
(A) Genomic organization of lst locus (previously CG8317) with location of P{EP}G424 and breakpoints of lst1 deletion.
(B) Schematic of preprolimostatin with predicted signal peptide and dibasic cleavage sites (red, underline). The highly conserved region used to generate Lst-15 is
indicated between cleavage sites #2 and #3 (magenta, bold). Lst antibodies and control peptide were generated using a 9-aa peptide as indicated (underline).
(C) Time-course of lst expression during starvation in wild-type adult flies, normalized to fed condition.
(D) Glucose levels in control and lst mutant flies.
(E) Lifespan of yw; lstctrl (n = 164) and yw; lst1 (n = 173) male flies. Median survival times are 57 and 43 days for yw; lstctrl and yw; lst1 flies, respectively. p < 0.0001
(log rank test).
(F) Ilp2 expression in adult yw; lst1 flies compared to isogenic controls (yw; lstctrl).
(G) Hemolymph levels of Ilp2HF in yw; lstctrl; Ilp2HF and yw; lst1; Ilp2HF flies (Ilp2HF homozygous). All data displayed as mean + SD. *p < 0.05, **p < 0.01, and
***p < 0.001 (nR 5 for all conditions). See also Figure S1.a powerful genetic model to address unresolved questions rele-
vant to mammalian metabolism (Baker and Thummel, 2007;
Erion and Sehgal, 2013; Leopold and Perrimon, 2007). Similar
to mammals, secretion of Drosophila insulin-like peptides (Ilps)
from neuroendocrine cells in the brain regulates glucose homeo-
stasis and nutrient stores in the fly (Broughton et al., 2005; Ge´m-
inard et al., 2009; Ikeya et al., 2002; Rulifson et al., 2002).
Ilp secretion from insulin-producing cells (IPCs) is responsive
to circulating glucose and macronutrients and is suppressed
upon nutrient withdrawal (Ge´minard et al., 2009; Kre´neisz
et al., 2010). Notably, recent studies have identified hormonal
and GPCR-linked mechanisms regulating the secretion of Ilps
from IPCs, suggesting further conservation of pathways regu-
lating insulin secretion in the fly (Ge´minard et al., 2009; Kwak
et al., 2013; Owusu-Ansah et al., 2013; Rajan and Perrimon,
2012).
In mammals, the incretin hormones gastric inhibitory peptide
(GIP) and glucagon-like peptide-1 (GLP-1) are secreted by enter-
oendocrine cells following a meal and enhance glucose-stimu-
lated insulin production and secretion from pancreatic b cells
(Campbell and Drucker, 2013; Creutzfeldt, 2005). Thus, we
postulated that a decretin hormone would have the ‘‘opposite’’
hallmarks of incretins. Specifically, a decretin (1) derives from
an enteroendocrine source that is sensitive to nutrient availabil-
ity, (2) is responsive to fasting or carbohydrate deficiency, and (3)
suppresses insulin production and secretion from insulin-pro-
ducing cells. However, like incretins, the action of decretins on
insulin secretion would be manifest during feeding, when a stim-
ulus for secretion is present.
Here, we identify a secreted hormone, Limostatin (Lst), that
suppresses insulin secretion following starvation in Drosophila.324 Cell Metabolism 21, 323–333, February 3, 2015 ª2015 Elsevier InWe show that lst is regulated by starvation, and flies deficient
for lst display phenotypes consistent with hyperinsulinemia.
We localize Lst production to glucose-sensing, endocrine
corpora cardiaca (CC) cells associated with the gut and show
that lst is suppressed by carbohydrate feeding. Using calcium
imaging and in vitro insulin secretion assays, we identify a
15-aa Lst peptide (Lst-15) sufficient to suppress activity of
IPCs and Ilp secretion. We identify an orphan GPCR in IPCs as
a candidate Lst receptor. Moreover, we show that Neuromedin
U (NMU) is likely a functional mammalian ortholog of Lst that
inhibits islet b cell insulin secretion. These results establish a
decretin signaling pathway that suppresses insulin output in
Drosophila.
RESULTS
CG8317 Encodes Limostatin, a Polypeptide
That Suppresses Insulin Production
To identify a hormone that may function as a decretin, we per-
formed an ectopic misexpression screen of selected starva-
tion-regulated Drosophila genes (Palanker et al., 2009; Zinke
et al., 2002) predicted to encode peptide hormones. Expression
of CG8317 in the fat body, a tissue capable of humoral secretion
(Ge´minard et al., 2009; Rajan and Perrimon, 2012), induced phe-
notypes consistent with insulin deficiency inDrosophila (Rulifson
et al., 2002), including hyperglycemia and developmental delay
(Figures S1A and S1B). CG8317 encodes a predicted primary
translation product of 139 amino acids with a signal peptide
and four putative dibasic cleavage sites, characteristic features
of metazoan pre-prohormones (Figures 1A and 1B). Quantitative
RT-PCR (qPCR) in fasting adult flies showed induction ofc.
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Figure 2. Obesity in lst Mutants
(A) Triglyceride content of control Ilp2-GAL4 and
Ilp2-GAL4>NaChBac flies.
(B and C) Whole-fly triglyceride content and nile
red staining of abdominal lipid droplets in adult lst1
flies and controls.
(D) Triglyceride content after silencing of IPCs
using Ilp2-GAL4 to drive UAS-Kir2.1 in yw; lstctrl
and yw; lst1 background, normalized to yw; lstctrl;
Ilp2-GAL4 > UAS-Kir2.1.
(E) Triglyceride levels in yw; lst1 and controls in
random fed, starved, and starved then overnight
re-fed flies. Data are normalized to yw; lstctrl fed
condition.
(F and G) Quantification of triglyceride depletion
after starvation and triglyceride accumulation
following refeeding after starvation; data from
experiment in (E). Scale bar 15 mm in (C). Data
displayed as mean + SD. *p < 0.05, **p < 0.01, and
***p < 0.001, (n = 5–8 per condition). See also
Figure S2.CG8317 by 16 hr with peak mRNA levels after 24–28 hr of
nutrient deprivation (Figure 1C), confirming results from whole-
genome expression analysis (Palanker et al., 2009; Zinke et al.,
2002). CG8317 and its predicted products appear to be
conserved in Drosophila species, including a 15-aa region
flanked by cleavage sites also conserved in mosquitoes and
other Insecta (Figure S1D). Inactive pre-prohormones undergo
post-translational processing, including cleavage at dibasic res-
idues, prior to secretion as bioactive peptides (Duckert et al.,
2004). To identify dibasic cleavage sites that are critical for
CG8317 function, we generated misexpression lines with argi-
nine/lysine to alanine substitutions at each of the four sites and
screened for phenotypes (see Experimental Procedures). Sub-
stitution of arginines 101 and 102, immediately N-terminal to
the most highly conserved region, eliminated CG8317 gain-of-
function phenotypes, suggesting that this dibasic cleavage site
is necessary for pro-hormone processing and function (Figures
1B, S1C, and S1D). Thus, CG8317 encodes a starvation-regu-
lated gene likely encoding a processed pre-propeptide that
can inhibit insulin production and secretion (see below). We
named CG8317 limostatin (lst) after Limos, the Greek goddess
of starvation.
To investigate lst function, we mobilized a P element (Bellen
et al., 2004) near lst and identified an imprecise excision that
deleted 2 kb encompassing the entire coding sequence (lst1
allele; Figure 1A). lst mRNA was undetectable in lst mutant flies
by qPCR, indicating that lst1 is a null allele. Expression of an lst
transgene rescued lst mutant phenotypes (see below). Insulin
deficiency in Drosophila produces hyperglycemia, starvation
resistance, and lifespan extension (Broughton et al., 2008,
2005; Rulifson et al., 2002). Thus, we hypothesized that lst-defi-
cient flies would display phenotypes consistent with insulin
excess. As expected, lst mutants were hypoglycemic and
short-lived compared to isogenic controls (Figures 1D and 1E).
We next assessed insulin production in lst mutants. Drosophila
Ilps-2, -3, and -5 are produced by IPCs, median neurosecretory
cells of the pars intercerebralis, and are essential regulators of
growth and metabolism (Gro¨nke et al., 2010; Ikeya et al.,Cell M2002; Rulifson et al., 2002). We measured transcript levels of
Ilp2, Ilp3, and Ilp5 by qPCR and found elevated mRNAs encod-
ing all brain-derived Ilps in lst1 flies during ad libitum feeding
(Figures 1F, S1E, and S1F). While expression and IPC accumu-
lation of Ilp protein have been used to assess insulin signaling in
Drosophila (Buch et al., 2008; Ge´minard et al., 2009), we sought
to directly measure circulating picomolar levels of Ilp2 in the he-
molymph. To do this, we generated mutant flies and isogenic
controls harboring a bioactive form of dual-epitope tagged
Ilp2, Ilp2HF, in place of the endogenous locus (Park et al.,
2014). If Lst functioned as a decretin, we hypothesized that
circulating Ilp2 levels would be elevated in lst mutants. ELISA
measurement of Ilp2HF revealed a significant increase in circu-
lating Ilp2HF in lst1 flies compared to controls (Figure 1G).
Collectively, these results demonstrate that lst is produced dur-
ing fasting and is required to suppress insulin production by
Drosophila IPCs.
Obesity in Hyperinsulinemic limostatin-Deficient Flies
Elevated insulin signaling can stimulate obesity in flies by
increasing both adipocyte number and lipid accumulation (DiA-
ngelo and Birnbaum, 2009). Consistent with this precedent,
increased IPC excitability by targeted expression of a bacterial
sodium channel (NaChBac) was sufficient to increase trigly-
ceride stores in adult flies compared to age-matched controls
(Figure 2A). Likewise, in hyperinsulinemic lst1 flies we found
triglyceride content was elevated to 150% of control values, us-
ing standard assays including colorimetry, nile-red staining, and
thin-layer chromatography (Figures 2B, 2C, and S2). To assess
whether IPC activity is necessary for obesity in lst mutants, we
generated lines that permit electrical silencing of IPCs through
targeted expression of the inward rectifying potassium channel
Kir2.1. Upon silencing of IPCs, we detected no difference in tri-
glyceride content of lst mutants and controls (Figure 2D). Thus,
lst mutant flies are obese and display phenotypes associated
with insulin excess.
To further evaluate the balance between catabolic and
anabolic activity in lstmutants, we fasted flies for 24 hr to depleteetabolism 21, 323–333, February 3, 2015 ª2015 Elsevier Inc. 325
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Figure 3. Lst is Produced in Gut-Associated
CC cells
(A) Expression of Lst-GAL4 > CD4::tdTomato and
AKH immunoreactivity in CC cells. Labels here and
below: cc, corpora cardiaca; ca, corpus allatum;
he, heart/dorsal vessel.
(B) Dense-core vesicle marker preproANF::EMD
(GFP) and Lst antibody staining of CC cells.
Outline marks ring gland. Arrow indicates CC cell
soma, arrowhead marks path of dorsal vessel.
(C) AKH and Lst immunoreactivity in ring gland of
control and lst mutant flies. Labels as above,
hatched lines denote boundary of ring gland.
(D–F) Glucose, circulating Ilp2HF (heterozygous
Ilp2HF flies), and triglyceride levels following
knockdown of lst in CC cells using Akh-GAL4
(lstRNAi) compared to isogenic controls (VDRCctrl).
(G) Triglyceride content in controls (yw; lstctrl; Akh-
GAL4), lst mutants (yw; lst1; Akh-GAL4) and
following rescue with UAS-lst (yw; lst1; Akh-GAL4/
UAS-lst). Scale bars 10 mm in (A)–(C). Data dis-
played as mean + SD. **p < 0.01,and ***p < 0.001.
See also Figure S3.lipid stores, then re-fed flies for 24 hr to promote lipid accumula-
tion (Figure 2E). Starvation-induced lipid depletion remained
fully intact in lst1 mutants and was even slightly elevated
(Figures 2E and 2F). Remarkably, lst mutants rapidly accumu-
lated triglycerides upon re-feeding and displayed significant
obesity after only 24 hr (Figures 2E and 2G). These results indi-
cate catabolic defects are not the principal basis for obesity in
lst mutants.
Lst Is Regulated by Carbohydrate Feeding in
Gut-Associated CC Cells
To identify the tissue source(s) of Lst, we generated an lst
reporter line (Lst-GAL4 > mCD4::tdTomato) and a monoclonal
antibody against the pre-propeptide (see Experimental Proce-
dures). Lst-GAL4-mediated expression of mCD4::tdTomato
co-localized with Adipokinetic hormone (AKH) in CC cells (Fig-
ure 3A). The CC cells comprise 14 gut-associated endocrine
cells that send projections to the midgut and secrete hormones
into the circulation from projections to the dorsal vessel (Cog-
nigni et al., 2011; Kim and Rulifson, 2004; Park et al., 2011).
CC cells secrete AKH, a hormone thought to be a functional or-
tholog of mammalian glucagon, indicating that CC cells have
roles analogous to preproglucagon-expressing cells in the
mammalian pancreas and gastrointestinal tract (Kim and Rulif-
son, 2004; Park et al., 2011). Lst protein co-localized with
AKH, and with the dense-core vesicle marker ANF-EMD (Rao
et al., 2001) in CC cell neurites ramifying on heart, consistent
with the postulated role of Lst as a secreted hormone (Figures
3B and 3C).326 Cell Metabolism 21, 323–333, February 3, 2015 ª2015 Elsevier Inc.Following specific knockdown of lst us-
ing RNAi (lstRNAi) in CC cells, Lst immuno-
reactivity was reduced or undetectable,
as in homozygous lst mutants (Figures
3C and S3A). Lst knockdown in CC cells,
but not the fat body (Figure S3B), recapit-
ulated the hypoglycemia, elevated cir-culating Ilp2HF levels, and obesity observed in lst1 mutant flies
(Figures 3D–3F). Thus, CC cells are a crucial physiological
source of Lst. To confirm that lst loss-of-function causes obesity
in lst mutants, we expressed UAS-lst specifically in the CC cells
of lstmutant flies. We observed reversion of lst1 obesity, with tri-
glyceride levels indistinguishable from those in controls (Fig-
ure 3G). Thus, Lst is principally produced and secreted by CC
cells, and phenotypes in lst mutants derive from Lst loss in CC
cells.
A critical feature of incretin hormones is their regulation by
carbohydrate feeding (Creutzfeldt, 2005). Thus, if Lst functioned
as a decretin, we postulated that elevated lst expression after
fasting should be reduced upon refeeding with carbohydrates.
Refeeding fasted flies with carbohydrates rapidly suppressed
lst mRNA expression (Figure 4A). By contrast, refeeding with
protein did not detectably affect lst expression (Figure 4B).
Hence, lst expression is increased by dietary carbohydrate re-
striction. Carbohydrate refeeding after fasting led to significant
increases of circulating Ilp2HF (Figure 4C). Consistent with our
finding that lst is required to suppress insulin, we found that
this post-prandial increase of circulating Ilp2HF was significantly
greater in lst mutants compared to controls (Figure 4C). In sum-
mary, lst is regulated by dietary carbohydrate and is required to
regulate insulin output in post-prandial settings.
A Peptide Derived from Lst Inhibits IPC Activity
and Insulin Secretion
Drosophila IPCs share electrophysiological properties with
mammalian pancreatic b cells, including coupling of electrical
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Figure 4. Lst Regulates Insulin Secretion in
Response to Dietary Sugar
(A and B) qPCR analysis of lst expression in wild-
type adult flies starved then refed for 30, 60, or
120 min with carbohydrate-only (A) or protein-only
(B) food. 0 time point indicates flies starved and
not refed.
(C) Hemolymph Ilp2HF levels in lstmutants (purple
bars) and controls (open bars) refed for 0, 30, or
60 min following starvation. 0 time point indicates
starved. Flies here homozygous for Ilp2HF. Data
displayed as mean + SD. *p < 0.05, **p < 0.01, and
***p < 0.001.excitation to induction of calcium transients (Kre´neisz et al.,
2010). Incretins such as GLP-1 augment insulin secretion from
b cells by increasing the frequency and amplitude of intracellular
calcium transients (MacDonald et al., 2002). If Lst functioned as a
decretin, we hypothesized it should decrease the excitability of
IPCs. To monitor IPC activity, we generated flies that produce
the genetically encoded calcium indicator GCaMP3 (Tian et al.,
2009) specifically in IPCs.We quantified in vivo GCaMP3 fluores-
cence of IPCs by confocal microscopy in brains of immobilized
live adult flies (see Experimental Procedures). GCaMP3 fluo-
rescence was dose-dependently attenuated (Figure 5A) by
exposure to a 15-aa peptide with carboxy-terminal amidation
(Lst-15) corresponding to the highly conserved Lst region (Fig-
ures 1B and S1D). In contrast, exposure to a control peptide
derived from an alternate domain in the pre-propeptide (Fig-
ure 1B) did not detectably affect GCaMP3 signal (Figure 5A).
These results illustrate that a conserved region of the Lst peptide
can regulate calcium signaling in IPCs.
To directly assess the effects of Limostatin on Ilp secretion, we
developed an in vitro assay to measure Ilp2HF secretion from
brain IPCs following exogenous application of purified Lst-15
peptide. Heads from Ilp21 gd2HF flies were cultured in artificial
hemolymph-like (AHL) solution for 30min, and Ilp2HF concentra-
tion in supernatants was measured by ELISA (Park et al., 2014).
Exposure to Lst-15 significantly depressed Ilp2HF secretion un-
der basal conditions (Figure 5B). Secretion remained modestly
depressed following addition of high-KCl AHL solution to depo-
larize IPCs (Figure 5B), and a control peptide had no effect on
Ilp2HF secretion (Figure 5B). Taken together, these results
further support classification of Lst as a peptide hormone and
suggest that Lst acutely regulates insulin secretion from IPCs
(and see below). Furthermore, we have identified a minimal ami-
dated peptide that is sufficient for the insulinostatic effect of Lst.
Our demonstration that Lst is a hormone (1) produced by gut-
associated endocrine cells, (2) regulated by carbohydrate re-
striction that (3) inhibits Ilp production, and secretion from IPCs
supports classification of Lst as a Drosophila decretin.
Knockdown of the GPCR CG9918 in IPCs Phenocopies
lst Loss of Function
Many neuropeptides signal through GPCRs (Taghert and Nita-
bach, 2012), and receptor activity or expression is often modu-
lated to balance signaling strength (Gardner and Nissenson,
2004). To identify a candidate receptor for Lst, we designed a
qPCR-based screen to reveal GPCRs encoded by mRNAs that
were both (1) reduced upon lst overexpression and (2) elevatedCell Min lst mutants. As proof of principle, ectopic expression of Akh
in fat body reduced expression of the G protein-coupled Akh re-
ceptor AkhR (data not shown). We identified three candidate re-
ceptorswithmRNA levels that appropriately and reciprocally var-
ied in this manner upon lst gain- or loss-of-function (Figure 6A).
Based on our findings that excitatory activity of the IPCs is
crucial to lst loss of function phenotypes (Figure 2D), we
reasoned that knockdown of a candidate Lst receptor specif-
ically in IPCs should phenocopy the lst1 mutation. Only IPC-
directed knockdown of the receptor encoded by CG9918
(CG9918RNAi) produced increased adiposity, accompanied by
elevated Ilp2 mRNA levels (Figures 6B and 6C), phenotypes
observed in lst1 flies.CG9918 has been called Pyrokinin 1 recep-
tor (PK1r), based on its reported affinity for Drosophila pyrokinin
Drm-PK-1 (Cazzamali et al., 2005), but other studies failed to
activate CG9918 with Drm-PK-1 or pyrokinins (Park et al.,
2002), a peptide class thought to regulate sex pheromone pro-
duction (Choi and Vander Meer, 2012). Consistent with a role
in lst signaling, CG9918RNAi in IPCs also increased hemolymph
Ilp2HF levels and endogenous lst expression (Figures 6D and
6E). To confirm expression of CG9918 in IPCs, we performed
fluorescent in situ hybridization (FISH) combined with immuno-
histochemistry (for Ilp2) in CG9918RNAi and controls. Hybridiza-
tion signal for CG9918 co-localized with Ilp2 protein in IPCs,
was reduced with CG9918RNAi and undetectable with sense
probes (Figures 6F and S4). Thus, we have identified CG9918
as a GPCR expressed in IPCs that negatively regulates insulin
expression and secretion in the adult fly.
To test further if CG9918 encodes a GPCR required for Lst
signaling, we reasoned that CG9918RNAi in IPCs should alter ef-
fects of purified Lst-15 peptide on insulin secretion. Compared
to controls, we observed that CG9918 knockdown prevented
the effects of Lst-15 on attenuating Ilp2HF secretion (Figure 6G).
These pharmacogenetic findings indicate that Lst regulates insu-
lin secretion directly in IPCs and support the view that CG9918
encodes an Lst receptor.
NMU Is a Functional Ortholog of Lst That Inhibits Insulin
Secretion by Human Islets
The GCPR encoded by CG9918 is conserved among a cluster of
receptors within a phylogenetic group of peptide receptors that
includes human Neuromedin U receptors (NMURs) (Metpally
and Sowdhamini, 2005). Among these receptors, CG9918 is
most closely related to human NMURs, displaying 32% conser-
vation with NMUR1 and 30% conservation with NMUR2 (Figures
S5A and S5B; Experimental Procedures). In humans and otheretabolism 21, 323–333, February 3, 2015 ª2015 Elsevier Inc. 327
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Figure 5. Lst-15 Inhibits Electrical Activity and Insulin Secretion from IPCs
(A) GCaMP3 fluorescence in head-fixed adult flies expressing GCaMP3 in IPCs under the control of the Ilp2 promoter. Baseline images from IPCs in standard AHL
(3mMglucose) before treatment. Treatment panel images were obtained 30 s after treatment with control peptide or Lst-15 (125 nM and 1 mM) diluted in standard
AHL and displayed with 16-color look-up table. IPC cell clusters are indicated by hatched outline, and individual cells in the imaging plane are numbered around
perimeter of the cluster. Average DF/F% from baseline for each condition are plotted (bottom, right).
(B) Normalized Ilp2HF protein secreted into supernatant fromDrosophila heads incubated for 30min in standard AHLwith control peptide or Lst-15 peptide (1 mM)
under basal and high-KCl conditions as indicated. Data are normalized to basal control condition. Scale bars 10 mm in (A). Data displayed as mean + SD.
***p < 0.001.mammals, peripheral effects of NMU are mediated by NMUR1,
while NMUR2 is primarily expressed in the CNS (Mitchell et al.,
2009). NMUR1 immunoreactivity and mRNA were detected in
human pancreatic islets in insulin+ b cells (Figures 7A, S5C,
and S5F). By contrast, little to no protein or mRNAwere detected
in glucagon+ a cells, somatostatin+ d cells, exocrine acinar cells,
or pancreatic ducts (Figures 7B, 7C, and S5D–S5F). In addition,
qPCR revealed expression of NMUR1mRNA in human gastroin-
testinal tissues with enrichment in pancreatic islets (Figure 7D),
consistent with prior reports (Howard et al., 2000). Lst is pro-
duced in CC cells that contact the Drosophila foregut. Thus,
we assessed NMU expression in human gastrointestinal organs.
NMU mRNA expression was enriched in human foregut organs
(stomach and duodenum) (Figure 7E). Immunofluorescence
localized NMU to ChgB+ duodenal cells with an ‘‘open-type’’
morphology adjacent to the lumen of intestinal glands (Figures
7F and 7G). These results support the view that NMU from a
gastrointestinal sourcemight impact insulin output by pancreatic
b cells.
To test directly if NMU can suppress insulin secretion, we pu-
rified human islets and assessed GSIS at a concentration of
NMU reported to elicit physiological responses (Kaczmarek
et al., 2006). NMU-25 potently suppressed GSIS from human is-
lets in static batch culture assays (Figure 7H, p < 0.001 for GSIS)
and islet perifusion experiments (Figures 7I–7K). AnNMUR165W
allele that encodes amutant peptide was previously found to co-
segregate in an autosomal dominant pattern with early-onset
obesity (Hainerova´ et al., 2006). In that study, a subset of carriers
displayed elevated insulin C-peptide levels; based on these find-
ings and mutation of the highly conserved NMU C-terminal
pentapeptide in this family, we reasoned that suppression of in-
sulin secretion might be impaired by the mutant NMU R165W
variant. In human islet perifusion assays, the R165W NMU328 Cell Metabolism 21, 323–333, February 3, 2015 ª2015 Elsevier Invariant failed to suppress insulin secretion (Figures 7K and
S5G) compared to wild-type NMU. These data suggest that
the human NMU R165W mutation represents a hypomorphic
loss-of-function allele and that impaired regulation of insulin
secretion by NMU could underlie metabolic changes in carriers
of this allele.
DISCUSSION
Limostatin is a peptide hormone induced by carbohydrate re-
striction from endocrine cells associated with the gut that sup-
presses insulin production and release by insulin-producing
cells. Thus, Drosophila Lst fulfills the functional criteria for a de-
cretin and serves as an index member of this hormone class in
metazoans. Results here also show that Lst signaling from
corpora cardica cells may be mediated by the GPCR encoded
by CG9918 in insulin-producing cells. In addition, our results
reveal cellular and molecular features of a cell-cell signaling sys-
tem in Drosophilawith likely homologies to a mammalian entero-
insular axis.
Reduction of nutrient-derived secretogogues, like glucose, is
a primary mechanism for attenuating insulin output during star-
vation in humans (Cahill et al., 1966) and flies (Colombani et al.,
2003; Ge´minard et al., 2009). Consistent with this, we found
that circulating Ilp2HF levels were reduced to a similar degree
in lstmutant or control flies during prolonged fasting (Figure 4C).
Therefore, lst was dispensable for Ilp2 reduction during fasting.
However, lst mutants upon re-feeding or during subsequent ad
libitum feeding had enhanced circulating Ilp2HF levels
compared to controls, findings that demonstrate a requirement
for Lst to restrict insulin output in fed flies. Thus, while induced
by nutrient restriction, Lst decretin function was revealed by
nutrient challenge. This linkage of feeding to decretin regulationc.
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Figure 6. CG9918 Is a Candidate Lst Receptor
(A) qPCR for expression of Drosophila GPCRs in lst overexpression (r4-G4 > UAS-lst) or lst1 loss of function. Expression changes in comparison to control are
indicated by gray (no change), green (decreased), purple (elevated), and black (not determined). Red arrowheads denote transcripts reciprocally regulated and
assessed in (B).
(B) Triglyceride levels following IPC specific knockdown of receptors identified in (A) (red arrowheads). Receptors encoded by CG9918, CG4395, and CG7285
were knocked down in IPCs using Ilp2-GAL4; UAS-Dcr2. AKHR was included as a negative control.
(C and D) Ilp2 expression and hemolymph Ilp2HF levels in CG9918RNAi flies and controls (Ilp2HF heterozygous here).
(E) lst expression in CG9918RNAi flies. Data in (B), (C), and (E) normalized to control condition.
(F) FISH for CG9918 mRNA with immunohistochemistry (IHC) using antibodies against Ilp2 in control and CG9918RNAi flies.
(G) Normalized Ilp2HF levels in supernatant from CG9918RNAi and control heads incubated with 1 mM Lst-15 (red bars) or Lst control peptide (open bars).
(H) Summary model for Lst signaling. Ingested carbohydrates levels are monitored by CC cells. Under carbohydrate-poor conditions, secreted Lst hormonally
suppresses activity and secretion of Ilps from insulin-producing cells (IPCs). Scale bar 25 mm in (F). Data displayed as mean + SD. *p < 0.05, **p < 0.01, and
***p < 0.001. See also Figure S4.of insulin output is reminiscent of incretin regulation and action
(Campbell and Drucker, 2013).
Recent studies have demonstrated functional conservation in
Drosophila of fundamental hormonal systems for metabolic
regulation in mammals, including insulin (Ikeya et al., 2002; Rulif-
son et al., 2002), glucagon (Kim and Rulifson, 2004; Lee and
Park, 2004), and leptin (Rajan and Perrimon, 2012). Here we
used Drosophila to identify a hormonal regulator of insulin
output, glucose, and lipid metabolism without an identified ante-
cedent mammalian ortholog—emphasizing the possibility for
work on flies to presage endocrine hormone discovery in mam-
mals. Gain of Lst function in our studies led to reduced insulin
signaling, and hyperglycemia, consistent with prior work by our
group and others (Broughton et al., 2005; Kim and Rulifson,
2004). By contrast, loss of Lst function led to excessive insulin
production and secretion, hypoglycemia, and elevated triglycer-
ides, phenotypes consistent with the recognized anabolic func-
tions of insulin signaling in metazoans, and with the few priorCell Mmetabolic studies of flies with insulin excess (Erion et al., 2012;
Rajan and Perrimon, 2012).
Prior studies show that somatostatin and galanin are mamma-
lian gastrointestinal hormones that can suppress insulin secre-
tion. Somatostatin-28 (SST-28) is a peptide derivative of the
pro-somatostatin gene that is expressed widely, including in
gastrointestinal cells and pancreatic islet cells. Islet somatostatin
signaling is thought to be principally paracrine, rather than endo-
crine, and serum SST-28 concentrations increase post-pran-
dially (D’Alessio et al., 1989; Strowski and Blake, 2008). Galanin
is an orexigenic neuropeptide produced throughout the CNS and
in peripheral neurons and has been reported to inhibit insulin
secretion (Fehmann et al., 1995). Unlike enteroendocrine-
derived hormones that act systemically, galanin is secreted
from intrapancreatic autonomic nerve terminals and is thought
to exert local effects (Dunning et al., 1986; Dupre´, 1988; Tang
et al., 2012). In addition, Galanin synthesis and secretion are
increased by feeding and dietary fat (Leibowitz et al., 2004;etabolism 21, 323–333, February 3, 2015 ª2015 Elsevier Inc. 329
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Figure 7. NMU Signaling Suppresses Insulin Secretion from Human b cells
(A–C) Immunoreactivity of NMUR1 and insulin (b cells), glucagon (a cells), or somatostatin (d cells) in adult human pancreas.
(D) qPCR analysis ofNMUR1 expression in human gastrointestinal tissues, including purified human islets and pancreatic ductal cells. Data expressed as relative
quantification (RQ) and normalized to liver sample. N.D., not detected.
(E) qPCR analysis of NMU expression in human gastrointestinal tissues. Data expressed as relative quantification (RQ) and normalized to liver sample.
(F) NMU immunoreactivity in villous mucosa of human duodenum. Mucosal villi (vl) oriented toward lumen at upper right of image. Hatched line in left panel
denotes boundary of mucosal layer. Magnification of boxed region in right panel shows base of duodenal gland (gl), with lumen outlined by hatched line and open-
type enteroendocrine cell immunoreactive for NMU. sm, submucosa.
(G) NMU and Chromogranin B immunoreactivity in open-type enteroendocrine cell. Lumenal edge of duodenal gland (gl) is marked by hatched line. Scale bars
10 mM in (A)–(C) and 20 mM in (D) and (E).
(H) Insulin secretion fromhuman islets from59-year-oldmale donor assayed in static batch assaywith vehicle or 100nMNMU-25.Data normalized to insulin content
and expressed as percent of total content. GSIS panel (right) displays ratio of stimulated (16.7 mM) to basal (2.8 mM) secretion. Data displayed as mean + SD.
(I) Insulin secretion from human islet perifusion assay using islets from 40-year-old male donor. NMU-25 (red trace) was applied at 100 nM and included in all
incubation solutions. Top diagram depicts stimulation protocol. IBMX, 3-isobutyl-1-methylxanthine.
(J) Quantification of insulin secretion area under the curve (AUC) from independent perifusion experiments (in Figures 7I, 7K, and S5I) using islets from three
human donors under stimulation conditions (16.7mMglucose or 16.7mM+ IBMX). Islets were treatedwith vehicle (open bars) or 100 nMNMU-25 (red bars). Data
displayed as mean + SEM.
(K) Insulin secretion in human islet perifusion assay using islets from a 49-year-old male donor. NMU-25 (red trace) and mutant NMU-25 R165W (blue) were
applied at 100 nM and included in all incubation solutions. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S5.
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Wang and Leibowitz, 1997). Thus, like incretins, output of SST-
28 and galanin are induced by feeding, but in contrast to incre-
tins, these peptides suppress insulin secretion. Further studies
are needed to assess the roles of these peptide regulators in
the modulation of insulin secretion during fasting.
While sequence-based searches did not identify vertebrate or-
thologs of Lst, we found that the postulated Lst receptor in IPCs,
encoded by CG9918, is most similar to the GPCRs NMUR1 and
NMUR2. In rodents, NMU signaling may be a central regulator of
satiety and feeding behavior (Hanada et al., 2004; Howard et al.,
2000), and this role may be conserved in other organisms (Pang
and Curran, 2014; Schoofs et al., 2014). In addition,NMUmutant
mice have increased adiposity and hyperinsulinemia (Hanada
et al., 2004), but a direct role for NMU in regulating insulin secre-
tion by insulin-producing cells was not identified. In rodents, the
central effects of NMU on satiety are thought to be mediated by
the receptor NMUR2; however, hyperphagia, hyperinsulinemia,
and obesity were not reported in NMUR2mutant mice (Bechtold
et al., 2009). Together, these studies suggest that a subset of
phenotypes observed in NMU mutant mice may instead reflect
the activity of NMU on peripheral tissues like pancreatic islets,
but this has not been previously shown. Notably, humans
harboring theNMU R165W allele displayed obesity and elevated
insulin C-peptide levels, without evident hyperphagia—further
suggesting that the central and peripheral effects of NMU reflect
distinct pathways that may be uncoupled (Hainerova´ et al.,
2006). Here we showed that NMU is produced abundantly in hu-
man foregut organs and suppresses insulin secretion from
pancreatic b cells, supporting the view that NMU has important
functions outside the CNS in regulating metabolism. Thus, like
the incretin GLP-1 (Drucker, 2006), NMU may have dual central
and peripheral signaling functions in the regulating metabolism.
Demonstration that NMU is a mammalian decretin will require
further studies on NMU regulation and robust methods to mea-
sure circulating NMU levels in fasting and re-feeding. In sum-
mary, our findings should invigorate searches for mammalian
decretins with possible roles in both physiological and patholog-
ical settings.
EXPERIMENTAL PROCEDURES
Drosophila Methods
Experimental crosses were maintained at 25C under 12 hr:12 hr light/dark
conditions and provided fresh food every 2 to 3 days. Unless otherwise indi-
cated, standard molasses (6% molasses, 5% corn meal, 2.5% baker’s yeast,
and 0.7% agar) food was used for all experiments. Adult flies were collected
2 days after eclosion and aged for 8–12 days on standard molasses food for
all experiments. Carbohydrate-only food was comprised of 15%W/V dextrose
or sucrose and 1% agar. Protein-only food was comprised of 10%W/V bacto-
peptone (BD). For starvation experiments, flies were tipped to fresh vials or
bottles containing 1% agar or wetted cotton plugs and fasted for 20–24 hr un-
less otherwise indicated. For re-feeding experiments, agar-starved flies were
tipped to foods prepared with food coloring and feeding was verified by visu-
alization of pigment in gut.
The lst1 allele was generated by imprecise excision of a P element upstream
of the lst gene in the yw; P{EP}G424 line (Bellen et al., 2004) using standard
methods. The extent of the deletion was assessed by PCR and sequencing.
The deletion spans 1,946 bp fragment (2R: 12462183.12464128 in the
genome assembly release r5.52), only removing the lst gene, including the
entire coding region. A control yw stock and the yw; lst1 line were then back-
crossed into the original yw; P{EP}G424 line to generate isogenic yw; lstctrl and
yw;lst1 stocks. To generate lines for epistasis experiments, yw; lstctrl and yw;Cell Mlst1 (located on chromosome II) were combined with transgenes or defi-
ciencies located on chromosome III by standardmethods to generate isogenic
flies. Thus, stocks were yw; lstctrl or yw; lst1 chromosomes I & II, and isogenic
for indicated transgenic or mutant chromosome III.
Drosophila metabolic assays were performed using protocols described in
detail (Tennessen et al., 2014). Insulin measurements in Drosophila were per-
formed using flies homozygous or heterozygous for the Ilp2HF transgene, as
indicated. Hemolymph Ilp2HF levels were quantified using custom made
ELISA assays as described in Park et al. (2014).
Human Tissues
Institutional review board approval for research use of tissue was obtained
from Stanford University School of Medicine and Vanderbilt University. Human
pancreata and islets were obtained from previously healthy, non-diabetic or-
gan donors by the Integrated Islet Distribution Program (IIDP). For histology
studies, fresh human pancreata and gastro-intestinal organs were fixed and
processed for sectioning by standard histology protocols. Pancreata from do-
nors aged 3, 23, and 30 years old were used in immunofluorescence studies.
Islets used in static batch incubation and perifusion assays were from donors
aged 3, 40, 49, 51, and 59 years old. Human gastrointestinal cDNA was ob-
tained from Clontech (Human Digestive System MTC panel, cat: 636746)
and derived from multiple donors. Human islet and pancreatic ductal cell
RNA for qPCR was obtained as described previously (Lee et al., 2013). Adult
human stomach slides used for histology were obtained from Abcam (cat:
ab4371). Adult human pyloric stomach and duodenum specimens used in his-
tology were procured by the National Disease Research Interchange (NDRI).
Human pancreas sections used for RNAscope 2.0 assays were obtained
from the Stanford Tissue Bank.
Peptides
Drosophila peptides used in this study were supplied by LifeTein (South Plain-
field). Peptide sequences are as follows: Limostatin-control peptide (Lst-ctrl),
AQPDSLRSKP; Limostatin-15 (Lst-15) AIVFRPLFVYKQQEI-amide. Human
NMU-25 was obtained fromSigma (N4284) and LifeTein (Hillsborough), human
NMU-R165W was obtained from LifeTein.
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